Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Steel Chemical Corporation (1723.TW)
Kaohsiung, TPE, TW
China Steel Chemical Corporation, together with its subsidiaries, engages in the production, processing, and sale of coal tar distillation, light oil, coke, and refined carbon material products in Taiwan, China, Australia, and internationally. The company offers coal chemicals, including coal and special tar pitches; creosote oils and refined tars; refined naphthalene mothball and chemical grades; benzene and toluene aromatics; and metallurgical cokes and dehydrated coke fines. It also provides carbon materials, such as anode-material precursors; anode materials for lithium-ion battery; activated carbon for EDLC; and fine carbon materials comprising green mesophase powder, carbonized mesophase powder, mesophase graphite powder, and advanced carbon materials. In addition, the company engages in the trading of related upstream and downstream products; production and sale of blast furnace slag powder and cement, gas-cooled blast furnace slag and converter, magnetic materials, specialty chemicals, and iron oxide; resource recycling; and steel structure manufacturing and sale. Further, it is involved in solar energy generation; biotechnology consulting services; and general investment activities. The company was founded in 1978 and is headquartered in Kaohsiung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60% | +0.12% | +5.11% | +15.43% | +15.10% | +20.85% | -10.93% | -26.84% | -23.44% | -25.52% | +666.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-23.9% Q1'26: -24.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-48.8% Q1'26: -18.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+6.4% Q1'26: +0.9% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+8.5% ★ Q1'26: +14.2% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.8% ★ Q1'26: +6.5% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.2% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×3.09× Q1'26: 2.23× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.74B
est: 5.84B (-1.8%)
|
5.14B
est: 5.10B (+0.8%)
|
6.24B
est: 6.29B (-0.8%)
|
8.56B
est: 8.32B (+2.8%)
|
7.54B
est: 7.52B (+0.4%)
|
5.36B
est: 5.38B (-0.3%)
|
7.98B
est: 7.92B (+0.8%)
|
10.46B
est: 10.63B (-1.6%)
|
8.32B
est: 7.51B (+10.7%)
|
7.65B
est: 7.55B (+1.3%)
|
5.82B
est: 5.86B (-0.8%)
|
6.88B
6.88B – 6.88B
+17.3% YoY
|
7.09B
7.09B – 7.09B
+3.1% YoY
|
| EBITDA |
1.72B
est: 1.38B (+25.0%)
|
1.43B
est: 1.20B (+19.1%)
|
1.57B
est: 1.48B (+5.8%)
|
2.09B
est: 1.96B (+6.6%)
|
2.06B
est: 1.77B (+16.2%)
|
1.28B
est: 1.27B (+0.9%)
|
1.67B
est: 1.87B (-10.6%)
|
2.25B
est: 2.50B (-10.3%)
|
2.22B
est: 1.65B (+34.3%)
|
1.91B
est: 1.66B (+14.9%)
|
925.57M
est: 1.29B (-28.2%)
|
1.51B
1.51B – 1.51B
+17.3% YoY
|
1.56B
1.56B – 1.56B
+3.1% YoY
|
| EBIT |
1.20B
est: 1.02B (+17.8%)
|
1.10B
est: 890.15M (+23.9%)
|
1.38B
est: 1.10B (+25.7%)
|
1.82B
est: 1.45B (+25.2%)
|
1.62B
est: 1.31B (+23.7%)
|
769.90M
est: 938.00M (-17.9%)
|
1.19B
est: 1.38B (-13.6%)
|
1.79B
est: 1.85B (-3.6%)
|
1.75B
est: 1.21B (+44.4%)
|
1.46B
est: 1.22B (+19.9%)
|
495.57M
est: 946.90M (-47.7%)
|
1.11B
1.11B – 1.11B
+17.3% YoY
|
1.15B
1.15B – 1.15B
+3.1% YoY
|
| Net Income |
1.24B
est: 1.26B (-1.8%)
|
1.03B
est: 1.00B (+2.7%)
|
1.16B
est: 1.11B (+4.8%)
|
1.51B
est: 1.52B (-0.9%)
|
1.29B
est: 1.36B (-5.2%)
|
716.89M
est: 808.05M (-11.3%)
|
1.10B
est: 1.13B (-3.0%)
|
1.70B
est: 1.67B (+2.2%)
|
1.44B
est: 1.25B (+14.7%)
|
1.21B
est: 1.22B (-1.1%)
|
615.82M
est: 579.41M (+6.3%)
|
793.60M
793.60M – 793.60M
+37.0% YoY
|
818.00M
818.00M – 818.00M
+3.1% YoY
|
| SGA |
247.46M
est: 218.32M (+13.3%)
|
272.07M
est: 190.79M (+42.6%)
|
245.42M
est: 235.16M (+4.4%)
|
280.68M
est: 311.09M (-9.8%)
|
281.47M
est: 280.90M (+0.2%)
|
219.02M
est: 201.05M (+8.9%)
|
259.03M
est: 296.07M (-12.5%)
|
357.59M
est: 397.24M (-10.0%)
|
298.04M
est: 298.73M (-0.2%)
|
333.27M
est: 300.34M (+11.0%)
|
307.21M
est: 233.21M (+31.7%)
|
273.58M
273.58M – 273.58M
+17.3% YoY
|
282.13M
282.13M – 282.13M
+3.1% YoY
|
| EPS |
5.37
est: 5.42 (-1.0%)
|
4.45
est: 4.31 (+3.2%)
|
5.00
est: 4.76 (+5.1%)
|
6.50
est: 6.54 (-0.6%)
|
5.57
est: 5.86 (-4.9%)
|
3.09
est: 3.47 (-11.0%)
|
4.73
est: 4.86 (-2.8%)
|
7.34
est: 7.16 (+2.5%)
|
6.18
est: 5.39 (+14.7%)
|
5.18
est: 5.25 (-1.3%)
|
2.65
est: 2.49 (+6.3%)
|
3.42
3.42 – 3.42
+37.0% YoY
|
3.52
3.52 – 3.52
+3.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets Equity Income UCITS ETF - Acc DEMR.L | 0.09% | 232.4K | 0.46% |
| 2 | WisdomTree Emerging Markets Equity Income UCITS ETF DEMD.L | 0.09% | 232.4K | 0.46% |
| 3 | WisdomTree Emerging Markets High Dividend Fund DEM | 0.08% | 3.24M | 0.63% |
| 4 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.08% | 32.9K | 0.54% |
| 5 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.06% | 1.10M | 0.58% |
| 6 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.05% | 8.16M | 0.07% |
| 7 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.04% | 28.8K | 0.74% |
| 8 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.04% | 255.9K | 0.65% |
| 9 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.04% | 42.2K | 0.42% |
| 10 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 81.9K | 0.74% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kuan Jen Fang | Chief Auditor | — | male |
| Li Kuo Li | GM, Chief Auditor, Chief of Finance, Accounting Supervisor & Corporate Governance | — | female |
| Ming-Dar Fang | President & Director | — | male |
| Wen Liang Tseng | President | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1723.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
